D B Whigan, A E Schuster
Index: J. Chromatogr. B, Biomed. Appl. 664(2) , 357-63, (1995)
Full Text: HTML
This paper describes the determination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in urine. The method involves sample clean-up by liquid-liquid extraction with ethyl acetate followed by high-performance liquid chromatographic (HPLC) analysis. The sample preparation may be performed either manually or automatically using a Zymark Py-robotic system. The chloro analog of the parent compound, CV-araU, is used as the internal standard. As low as 0.1 microgram of analyte per ml of urine can be measured. This sensitivity is adequate for pharmacokinetic studies but could be improved quite easily if necessary.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
(E)-4,4,4-TRIFLUORO-1-PHENYL-BUT-2-EN-1-ONE
CAS:69304-49-0 |
C6H5BrN2O2 |
|
Biochemical modulation of the catabolism and tissue uptake o...
1999-11-01 [Magn. Reson. Med. 42(5) , 936-43, (1999)] |
|
Deoxyribosyl exchange reactions leading to the in vivo gener...
1986-05-15 [Biochem. Pharmacol. 35(10) , 1647-53, (1986)] |
|
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)urac...
1986-02-01 [J. Med. Chem. 29 , 213, (1986)] |
|
Mechanism-based inactivation of human dihydropyrimidine dehy...
2000-05-01 [Mol. Pharmacol. 57(5) , 899-905, (2000)] |
|
Relationships among plasma [2-(13)C]uracil concentrations, b...
2005-03-01 [Drug Metab. Dispos. 33(3) , 381-7, (2005)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
